There is new data coming out on complementary and alternative therapies for dementia, including supplements, mindfulness techniques, exercise, music therapy, and more, said Kalin Clifford, PharmD, BCGP, BCPS, FASCP, associate professor, Geriatrics Division, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy.
There is new data coming out on complementary and alternative therapies for dementia, including supplements, mindfulness techniques, exercise, music therapy, and more, said Kalin Clifford, PharmD, BCGP, BCPS, FASCP, associate professor, Geriatrics Division, Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy.
Transcript
How much research is there on complementary and alternative therapies for dementia, and what additional research is needed?
I would say with complementary and alternative therapies, this is a new area that we are starting to see some data in, and with complementary and alternative therapies, it's not just supplements. It's also looking at diet; it is also looking at mindfulness techniques. Exercise, acupuncture, and acupressure are some therapies that we are looking into. Music therapy is also something that has had a lot of attention in the last few months as well and has shown some positive benefit.
In regards to additional research that's needed, I think where we need to start looking at more is looking specifically at how can we implement these and make these easier to implement. A lot of times with music therapy, you have to have a lot of the equipment. Sometimes a lot of the families that I work with just don't have access or don't have a third iPod or second set of headphones or something else to really optimize the benefit of it. So, trying to make sure that if you are going to go to these therapies that the family members and the loved ones and the caregivers have enough resources to it. And that's where a lot of the research dollars probably need to be spent, is how do we expand access to all these options for care?
What symptoms of dementia do complementary and alternative therapies most effectively treat?
Complementary and alternative medicine and complementary/alternative therapy is such a wide category. We break it down into 5 domains, and within those 5 domains, they have at least 15 to 20 different recommendations of what could be done. But from what I've seen in my practice, is a lot of the herbal supplements are sort of seeing some benefit with maybe helping delay the loss of function and maybe helping delay the loss of cognition. They don't really help with the behavioral side of Alzheimer's dementia per se. Now with music therapy, mindfulness meditation, we are seeing a lot of improvement with more of the behavioral side, and we are seeing a decrease in behavior and psychosocial symptoms of dementia, as well.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More